Taiwo Opeyemi Aremu

Dr. Taiwo Opeyemi Aremu

University of Minnesota - Twin Cities
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2022 in Pharmacy
Verified
Journal Article
Open access
PDF file
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
OOOluwatosin Esther Oluwole
Oluwatosin Esther Oluwole
Kehinde Oluwatosin AdeyinkaKehinde Oluwatosin Adeyinka
Kehinde Oluwatosin Adeyinka
Jon SchommerJon Schommer
Jon Schommer
The indices of patients’ health outcomes have historically included recurrence of symptoms, number of emergency visits, hospitalization and re-admission rates, morbidity, and mortality. As significant healthcare players, providers can influence these events, including the timeliness of diagnosis and disease management, the cost of treatment, access to health insurance, and medication adherence. Beyond healthcare availability and access, the ability of patients to adhere to providers’ treatment recommendations goes a long way to serve as a recipe for improving patient outcomes. Unfortunately, medication nonadherence has been prevalent, culminating in worsened health conditions, increased cost of care, and increased healthcare spending. This article provides some innovative ideas and good considerations for encouraging medication adherence. Improving providers’ and patients’ education and adopting active and passive communication, including consented reminders, could enhance compliance. Embracing partnerships between providers’ organizations and faith-based and community organizations could drive adherence. Adopting an income-based cap on out-of-pocket spending and adapting the physical properties, bioavailability, and dosage regimen of medications to accommodate diverse patient population preferences could encourage refills and compliance. Good medication adherence can culminate in improved patient outcomes.

10 October 2022 in Plants
Verified
Journal Article
Open access
PDF file
Christiana Adeyinka OdebunmiChristiana Adeyinka Odebunmi
Christiana Adeyinka Odebunmi
Tomi Lois AdetunjiTomi Lois Adetunji
Tomi Lois Adetunji
Ademola Emmanuel AdetunjiAdemola Emmanuel Adetunji
Ademola Emmanuel Adetunji
AOAhmed Olatunde
Ahmed Olatunde
OOOluwatosin Esther Oluwole
Oluwatosin Esther Oluwole
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
Coronavirus disease 2019 (COVID-19) has extensively spread worldwide with high mortality. Besides vaccination, the United States Food and Drug Administration approved only one oral medication as a treatment. Medicinal plants with antiviral and immunomodulatory properties could be explored as complementary treatments for COVID-19. Ogbomosho is home to such plants traditionally used to treat infectious diseases in Nigeria, making it relevant in complementary medicine. An ethnobotanical survey of medicinal plants used to treat COVID-19 and related ailments, including cough and flu in Ogbomosho South and North Local Government Areas, Nigeria, was conducted using a semi-structured questionnaire. Information was obtained from 56 participants, consisting of different groups of individuals with native knowledge of medicinal plants, and ethnobotanical indices, including the frequency of citation (FC), relative frequency of citation (RFC), and fidelity level (FL) were computed. Twenty-six medicinal plants (17 families) were used to treat COVID-19, 31 (20 families) for cough, and 29 (19 families) for flu. The most cited plant was Zingiber officinale (FC = 10; RFC = 0.18; FL = 18%) for treating COVID-19, Citrus limon (FC = 13; RFC = 0.23; FL = 23%) for cough, and Zingiber officinale (FC = 9; RFC = 0.16; FL = 16%) for flu. Leaves were the most used plant part for treating COVID-19 and flu, while the bark was the most used for cough. Trees and herbs were the most cited plant growth forms. The herbal remedies were mostly prepared by decoction and infusion and were mainly administered orally. Further research should be conducted on the identified species for the scientific validation of their antiviral and immunomodulatory efficacies and safety for use.

22 September 2022 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
OOOlihe Okoro
Olihe Okoro
EVElyse Carter Vosen
Elyse Carter Vosen
KAKay Allen
Kay Allen
JKJanet Kennedy
Janet Kennedy
RRRenee Roberts
Renee Roberts
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
Background: The COVID-19 pandemic has had a disproportionate effect on the Black/African American population. In addition to the higher infection rates and the worse outcomes, there were other unintended consequences of the pandemic. The study objective was to determine the impact of COVID-19 on the Black/African American community. Methods: A needs assessment was conducted using a mixed-methods approach. To address this specific study objective, an item included in the survey questionnaire asked respondents (n = 183) about their greatest worry related to CODID-19. Interviews and focus group discussions were conducted to further explore individual and community perceptions. Results: The areas of greatest concern were Health (41.0%), Family (25.1%), Finances (8.2%), and Education (4.9%). The needs assessment revealed that the COVID-19 pandemic had a profound impact on the mental health and wellness, healthcare access and utilization, and social aspects of life the Black community. Emerging themes revealed that there was worsening mental health for many, limited healthcare access and under-utilization, and profound disruption of the social cohesive identity of the Black/African American community. Conclusion: Pre-existing structural inequities are implicated in the mental health impact, as well as the under-utilization of and limited access to healthcare services in the Black/African American population. The impact on social well-being emphasizes the important role of culture in the population health of communities of color, further supporting the need for culturally-responsive public health interventions when targeting these communities.

6 August 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
KSKarim Thomas Sadak
Karim Thomas Sadak
MGMilki Gemeda
Milki Gemeda
MGMichelle C. Grafelman
Michelle C. Grafelman
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
JNJoseph P. Neglia
Joseph P. Neglia
JMJude Mikal
Jude Mikal
Background: Survivor‐focused care for adolescent and young adult (AYA) childhood cancer survivors (CCS) often involves their parents. Recognizing the importance of parents in the ongoing care of CCS, our study sought to identify key aspects of a successful transition for CCS from pediatric‐ to adult‐centered care from the parent perspective.Methods: We conducted qualitative interviews with 26 parents of CCS who were receiving care in the long‐term follow‐up (LTFU) clinic at a single institution. We used a semi‐structured interview protocol with the parents and conducted a thematic content analysis.Results: Using a constant comparison approach, data revealed three primary themes regarding parents’ perspectives toward ensuring a seamless transition from pediatric‐ to adult‐centered follow‐up care: (1) the transition needs to include seamless communication between all involved parties, (2) survivors need to demonstrate sufficient health care self‐efficacy in order to achieve a successful transition, and (3) the survivor‐focused care should include support for survivors’ overall well‐being, including financial and health insurance literacy.Conclusions: For parents of AYA CCS, the optimal pediatric to adult care transition model should include mechanisms that facilitate communication between parents, CCS, and survivor‐focused providers while also supporting self‐efficacy and financial literacy as it relates to health insurance.

Verified
Journal Article
Open access
PDF file
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
CSChinar Singhal
Chinar Singhal
OAOluwafemi Augustine Ajibola
Oluwafemi Augustine Ajibola
EAEmmanuel Agyin-Frimpong
Emmanuel Agyin-Frimpong
ASAkua Asantewaa Appiah-Num Safo
Akua Asantewaa Appiah-Num Safo
OOOlihe Okoro
Olihe Okoro
Background: Malaria infection remains one of the leading causes of death in sub-Saharan Africa. Over the years, several measures have been implemented for the prevention of malaria, including vector control with insecticide-treated nets, indoor residual spraying, and seasonal or traveling prophylactics. In 2021, the World Health Organization (WHO) approved the use of the malaria vaccine in children. We conducted a cross-sectional survey study in three sub-Saharan African countries—Uganda, Ghana, and Nigeria—to assess public awareness of the malaria vaccine among the residents of these countries. Method: A cross-sectional, web-based survey was conducted between time January 2022 and April 2022 using Qualtrics® software (Version number: April 2022; Qualtrics, Provo, UT, USA). A total of 3896 responses were analyzed using SAS OnDemand for Academics software. Linear regression model was used to assess the relationship between the demographic characteristics and awareness of the malaria vaccine, using a level of significance (alpha) of 0.05. Result: Overall, there was significant association between the level of education and public awareness of the malaria vaccine in each of the countries studied. Gender and place of residence were associated with awareness in Nigeria and Uganda, while younger respondents were more likely to be aware of the malaria vaccine in Ghana. Conclusion: Given the negative impact of lack of awareness and knowledge, misinformation and conspiracy theories on immunization programs, public health campaigns preceding the population-wide roll-out of the novel malaria vaccine should target the less-educated, and those residing in more rural areas, while assuring equitable access to the malaria vaccine across sub-Saharan Africa.

18 March 2022 in Frontiers in Tropical Diseases
Verified
Journal Article
Open access
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
OAOluwafemi Augustine Ajibola
Oluwafemi Augustine Ajibola
OOOluwatosin Esther Oluwole
Oluwatosin Esther Oluwole
Kehinde Oluwatosin AdeyinkaKehinde Oluwatosin Adeyinka
Kehinde Oluwatosin Adeyinka
SDStephen Oreoluwa Dada
Stephen Oreoluwa Dada
OOOlihe Nnenna Okoro
Olihe Nnenna Okoro
Looking Beyond the Malaria Vaccine Approval to Acceptance and Adoption in Sub-Saharan Africa